AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. KOBAYASHI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Revenue growth (%)

KOBAYASHI PHARMACEUTICAL CO.,LTD.【JP:4967】

Market cap
¥455B
P/E ratio
43.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Dec 31, 20250.1-101.99%
Dec 31, 2024-4.5-204.62%
Dec 31, 20234.3-38.93%
Dec 31, 20227.1+125.08%
Dec 31, 20213.2-130.17%
Dec 31, 2020-10.4-3170.59%
Dec 31, 20190.3-95.03%
Dec 31, 20186.8-52.00%
Dec 31, 201714.3-320.59%
Dec 31, 2016-6.5-193.49%
Mar 31, 20166.9+732.53%
Mar 31, 20150.8-82.49%
Mar 31, 20144.7-164.58%
Mar 31, 2013-7.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)